Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Haibo Xue
Observed name:
HAIBO XUE
Institution:
Binzhou Medical University
Observed institution:
Binzhou Medical University
ORCID:
0000-0002-0495-3349
Observed ORCID:
0000-0002-0495-3349
OpenAlex ID:
A5121992885
Efficacy and safety of cAMP signalling-biased GLP-1 analogue ecnoglutide monotherapy versus placebo in patients with type 2 diabetes (EECOH-1): a multi-centre, randomised, double-blind, placebo-controlled, phase 3 trial
2026
·
Dalong Zhu
, Weimin Wang
, et al.
·
Nature Communications
·
9
PDF
HMGB1 dysregulation: a neuroimmune bridge to cognitive impairment in autoimmune thyroiditis
2026
·
Jue Wang
, Gaoping Chu
, et al.
·
Frontiers in Immunology
·
1
PDF
2849-LB: Efficacy and Safety of cAMP-Biased Ecnoglutide vs. Unbiased Semaglutide in Adults with Obesity: Twenty-Week Results from a Multicenter, Randomized, Open-Label, Phase 2 Study
2026
·
LINONG JI
, LEILI GAO
, et al.
·
Diabetes
[Foxo1 mediates immune damage in autoimmune thyroiditis by regulating the differentiation and function of Th17 cells].
2026
·
Ling Gan
, Chengyan He
, et al.
·
PubMed
γ-Secretase inhibitor ameliorates thyroid autoimmune damage via blocking Notch1 signaling and reducing γδT17 cells in EAT mice
2026
·
Jue Wang
, Longfei Ding
, et al.
·
Endocrine Journal
Show more works
View as search
Works count:
5
Citation count:
10
H-index:
1
I10-index:
Year
Topic
Type